dr. axel grothey on bevacizumab beyond progression in metastatic colorectal cancer
Published 11 years ago • 413 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
7:22
statement axel grothey on the role of bevacizumab in the tml & dream study
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
4:28
introduction: bevacizumab versus cetuximab in metastatic colorectal cancer
-
2:03
dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
-
4:16
fire-3 study: cetuximab versus bevacizumab in metastatic colorectal cancer
-
8:00
hope for cancer patients: liver transplant for colorectal liver metastasis - transmet trial
-
22:50
update: left versus right sided colon cancers: biomarkers versus biology
-
4:08
meet alexia: stage iv colon cancer survivor
-
11:50
colon cancer management - dr. axel grothey, part 1
-
11:07
future analyses from the 80405 metastatic colorectal cancer trial
-
0:57
dr. axel grothey examines the use of adjuvant oxaliplatin in colon cancer
-
29:15
icaho20 - asco direct™ highlights - dr. axel grothey - colorectal cancer
-
1:48
dr. grothey discusses novel agents for colorectal cancer
-
36:13
binaytara foundation_dr. axel grothey's talk on colon cancer
-
8:19
second-line management of patients with metastatic colorectal cancer
-
0:57
dr. grothey on biomarkers to inform metastatic crc treatment decisions
-
1:53
the role of sidedness in colorectal cancer
-
1:35
dr. eng on the treatment landscape in metastatic colorectal cancer
-
1:43
axel grothey, md | what is signatera?
-
6:17
colorectal cancer & ctdna updates with dr. axel grothey
-
6:15
treatment beyond progression for metastatic rcc
-
22:46
mutational testing and the treatment of colorectal cancer